Navigation Links
Dr. Liza Solomon, HIV/AIDS Expert, Joins Abt Associates as Principal Associate in Company's Domestic Health Division
Date:8/5/2009

CAMBRIDGE, Mass., Aug. 5 /PRNewswire/ -- Liza Solomon, Dr.P.H., a noted HIV/AIDS public policy leader and the former Director of the Maryland State AIDS Administration has joined Abt Associates as a principal associate in its Domestic Health Division. In addition to her public service, Dr. Solomon brings over three decades of additional public health experience in areas such as epidemiology, women's health, and head and extremity injury and trauma.

Dr. Solomon will be playing senior roles in developing, managing, and evaluating HIV/AIDS programs on behalf of such Abt Associates clients as the U.S. Centers for Disease Control and Prevention (CDC), and the U.S. Health Resources and Service Administration. She will also be involved in projects that draw on her expertise in other healthcare specialties, as well as health policy management and health care reform.

"We are delighted that Liza Solomon has joined our team," said Dr. Scott W. Royal, division vice president for Domestic Health. "She brings a wealth of diverse experience and expertise -- clinical and research, public and private sector, policy and administrative -- with numerous potential applications to our core healthcare-practice areas."

Dr. Deborah Klein Walker, vice president and leader of the health division's public health practice area, added: "We are confident that Liza's broad capabilities and unique perspective will enable her to make valuable contributions to our practice and our business."

Dr. Solomon served for nine years as director of the AIDS Administration at the Maryland Department of Health and Mental Hygiene, where she had responsibility for managing statewide HIV activities including oversight of Maryland's HIV care and treatment programs, HIV surveillance initiatives, and responsibility for all CDC funded prevention activities in the state. Immediately prior to joining Abt Associates, Dr. Sol
'/>"/>

SOURCE Abt Associates
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. LSTM leads project to develop HIV/AIDS strategy for Libya
2. H1N1 Swine Flu Leads to Cancellation of HIV/AIDS Summer Camp. One Heartland Announces Campaign to Fund Alternative Camp Session for 82 Children.
3. BD/PEPFAR Lab-Strengthening Initiative Marks Progress in Fight Against HIV/AIDS and TB in Sub-Saharan Africa
4. FAIR CEO Blasts Kaiser Foundation & Public Agenda HIV/AIDS Study Results as "Absolute Nonsense"
5. Brazil proves developing countries can use generic medicines to fight HIV/AIDS epidemic
6. Video: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas
7. National Minority Quality Forum to Release Groundbreaking National HIV/AIDS Atlas
8. PHOENIX-AHF/Magic Johnson HIV Testing Caravan & Southwest Center for HIV/AIDS to Host Free HIV Testing Event at Off Chute Too
9. Marijuana rivals mainstream drugs for HIV/AIDS symptoms
10. Thousands Rally in Anaheim to Help People With HIV/AIDS
11. Pelosi Remarks at amfAR Conference on Future Directions in Fight Against HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 Dale Buchanan, owner of Supreme ... have a weight loss contest for his students in the ... students are not competing for their own prize or against ... for the Tri County Humane Society in Boca ... mine loses between January 4 and February 28, 2010 I ...
(Date:12/16/2009)... in the ,70s, study finds , , TUESDAY, Dec. 15 ... the United States than it was more than 30 ... Researchers compared National Health and Nutrition Examination Survey data ... 1972 and from 8,339 black and white participants from ... years old. , The prevalence of myopia increased from ...
(Date:12/16/2009)... interval lessens complication risks , , TUESDAY, Dec. 15 (HealthDay News) ... such a profound impact on your life that you just ... new study suggests that you might want to wait at ... than 11 months could be even better. , The ... than six months, the chances of the baby dying, being ...
(Date:12/16/2009)... money to help clothe children in need. , ... ... cleaner Dryclean USA Florida , along with Atlantic Awnings of Miami, ... help clothe children in need by collecting funds on behalf of ... cards, with delivery of their clean clothes, and pamphlets requesting donations ...
(Date:12/16/2009)... 2009) Unisense FertiliTech A/S has received a further 1.6 million Euro ... the EmbryoScope™ Embryo Monitoring System in order to meet the rapidly ... by LD Pensions and Unisense A/S that continue to own each ... ... (PRWEB) December 16, 2009 -- Unisense FertiliTech A/S has received a ...
Breaking Medicine News(10 mins):Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations 2Health News:Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 2
... product revenue and reduced expenses continue to drive solid cash ... (Nasdaq: WCRX ) today announced its results for ... in the quarter ended December 31, 2008 totaled $242.5 million, ... for the year ended December 31, 2008 totaled $938.1 million, ...
... Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical ... company,s premier dental pharmaceutical product. OraVerse is the ... accelerates the return to normal sensation and function ... and unnecessary lingering soft tissue anesthesia following routine ...
... Feb. 27 /PRNewswire-Asia/ -- GE Healthcare, a,leading ... suite of,Centricity solutions targeted for hospitals and ... and advanced clinical capabilities,the suite provides the ... acquisition from Dynamic Imaging. , ...
... -- endorsed by,NaturalNews, Organic Consumers Association, Life Extension ... freedom groups --,calls for an end to FDA ... Its ten provisions also call for full income ... to the psychiatric drugging of,children, the end of ...
... Nursing Productivity in the Treatment of Renal Disease , ... ... 2009 -- iSirona®, an innovative provider of data automation solutions ... agreement with NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer ...
... Healthy Directions, LLC, is proud to announce the launch of searchjointpain.com, a ... conditions and solutions. , ... Potomac, MD (PRWEB) February 27, 2009 -- ... to announce the launch of searchjointpain.com , a new informational Web ...
Other Medicine News:Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 2Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 3Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 4Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 5Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 6Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 7Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 8Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 9Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 10Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 11Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 12Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 13Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 14Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 15Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 16Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 17Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 18Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 2Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 3Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 4Health News:GE Healthcare Extends Leading Web-Based Imaging Solutions to Asia 2Health News:GE Healthcare Extends Leading Web-Based Imaging Solutions to Asia 3Health News:Health Freedom Groups Join in Launch of Grassroots Health Revolution Petition at HealthRevolutionPetition.org 2Health News:iSirona Signs Reference Selling Agreement with NxStage 2Health News:Healthy Living Network Announces Launch of New Joint Pain Web Site 2
(Date:12/16/2009)... 16 The Boards of Silence Therapeutics ... to announce the merger of their businesses to ... RNAi (RNA interference). The enlarged company, to ... discovery, development and delivery technologies, a broad internal ... of intellectual property. ,, The Directors believe ...
(Date:12/16/2009)... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ... 3 registration clinical trial for KRX-0401 (perifosine), ... / refractory multiple myeloma patients. ,, The ... to Assess the Efficacy and Safety of ... (Velcade®) and Dexamethasone in Multiple Myeloma Patients ...
(Date:12/16/2009)... 16 , ... Daniel,Tome,s Supervision and Published* in November 2009, in ... Society "Bone", Reveal new Benefits for,Peptan(TM) in Osteoporosis ... to consumer concerns regarding long-term bone health,Rousselot has ... to demonstrate,that an oral intake of Peptan(TM) may ...
Breaking Medicine Technology:Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 2Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 3Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 4Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 5Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7Published in "Bone" Journal, Scientific Researches Confirm Peptan(TM) Hydrolyzed Collagen Benefits on Bone Health 2GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 1GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 2Cellular telephones to expand knowledge of health behaviors and microorganisms in adolescent males 49272 1Cellular telephones to expand knowledge of health behaviors and microorganisms in adolescent males 49272 2Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 1Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 2Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 3Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 4
... 2007 /PRNewswire-FirstCall/ --,CuraGen Corporation announced today that ... deacetylase (HDAC) inhibitor being,investigated for the treatment ... for the prevention of severe oral mucositis,will ... for Cancer,Research (AACR) 2007 Annual Meeting in ...
... April 11, 2007 /PRNewswire-FirstCall/ --,Advanced Magnetics today ... clinical trials of ferumoxytol as an,intravenous (IV) ... at approximately 6:00 pm EDT as posters ... in Orlando,Florida. These posters are available in ...
Other Medicine Technology:CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 2CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 3CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 4Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 2Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 3Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 4Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 5Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 6Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 7Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 8
... With the increase in Endoscopic cases it is ... Monitor with the Surgical Light. This combination ... without having to adopt an uncomfortable pose. ... including the NUVO Monitoring System. As such ...
... This configuration offers all the performance of a ... perfectly for use in Outpatient Settings, Minor Procedure ... Mounting two single lights either side of the ... in a General OR when combining Flat Screen ...
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously....
Medicine Products: